CurveBeam AI, founded in 2009, is a leading player in the Health Care, Manufacturing, and Marketing industries, with its headquarters in the United States. Specializing in Weight Bearing CT (WBCT) Imaging Systems for the Orthopedic and Musculoskeletal (MSK) specialties, the company has also developed AI-Driven Applications for WBCT Imaging and HR-pQCT Imaging for Bone Health. With a workforce of 51 employees, CurveBeam AI has set a remarkable legacy by installing more than 160 systems globally at leading orthopedic institutions. Its expertise lies in examining bone and joint alignment in a functional position, allowing for better diagnosis of lower extremity conditions such as flat foot, patellar instability, and hip dysplasia.
As of 31 January 2023, CurveBeam AI has secured a significant $25.00M in its latest funding round. This substantial investment has been made possible through the support of prominent investors including Frazier Healthcare Partners, Karst Peak Capital, Firetrail Investments, and Ilwella. With global operations headquarters situated in Hatfield, PA, USA, and a corporate office in Melbourne, VIC, Australia, the company manages product development, regulatory affairs, manufacturing, operations, marketing, sales, customer care, as well as AI research and development, corporate finance, and IP functions. As an unlisted public company, CurveBeam AI continues to bolster its presence in the industry with the strong backing of several major professional investors.
